Advancing Breakthrough Therapies Through Strategic Partnerships
Who We Are
Dawn Therapeutics is a clinical-stage biotechnology company developing precision-targeted gene and RNA therapies for rare and complex diseases. We specialise in tissue-specific delivery platforms that overcome the biggest barrier in genetic medicine: getting the therapeutic payload to the right cells, at the right time, with the right effect.
Our Mission
Our Vision
To transform the lives of patients and families affected by CNS disorders, lysosomal storage diseases, and musculoskeletal conditions through scientific innovation, ethical responsibility, and global collaboration.
Our Mission
- Patient-Centricity: Every decision begins with patient benefit in mind.
- Scientific Excellence: Pursuing breakthroughs with rigour, creativity, and data integrity.
- Collaboration: Working across sectors with clinicians, researchers, advocacy groups, and industry partners.
- Integrity: Holding ourselves accountable to the highest ethical standards.
Sustainability: Innovating with environmental and social responsibility in mind
Our Expertise
Dawn Therapeutics brings together leaders from:
- Gene Therapy & RNA Therapeutics Development
- Neurology, Genetics, and Musculoskeletal Research
- Regulatory Affairs & Clinical Trial Management
- Manufacturing & Commercialisation
Our proprietary delivery technologies are designed for brain, cartilage, muscle, and liver targeting, unlocking treatment potential in diseases previously considered untreatable.
Our Story
Founded with the vision to bridge the gap between cutting-edge science and patient impact, Dawn Therapeutics emerged from a team of scientists, clinicians, and entrepreneurs united by a shared goal — making targeted genetic therapies a reality for the people who need them most.
